DCGI to Manufacturers of 2 FDCs to Submit Applications Within 3 Months

The Drugs Controller General of India (DCGI) has instructed the makers of two fixed dose combinations (FDCs) approved before 1988...

Honeywell launches AI-powered technology for Healthcare testing

Honeywell has announced a revolutionary technology, Digital Holographic Microscopy that uses artificial intelligence (AI) to quickly count and sort microscopic particles or cells. The revolutionary technology can revolutionize several industries by..

Indian pharma drives innovation to enhance its API capabilities

Indian pharmaceutical companies have been concentrating on innovation and process advancement to enhance their skills in active pharmaceutical ingredients (APIs)...

Merck Plans Workforce Expansion in India by Year-End

Merck, a company better known as MSD outside of the United States and Canada, stated Wednesday that it would expand its Indian locations over the end of the year. The U.S. based pharmaceutical company...

Glenmark Pharma launches 10 mg/10 mL Epinephrine Injection USP

A new multiple-dose vial of epinephrine injection USP, 10 mg/10 mL (1 mg/mL), has been introduced by Glenmark Pharmaceuticals Inc., USA (Glenmark).

C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub

The Indo-French Life Sciences Sister Hub Innovations are being established under the aegis of the Centre for Cellular and Molecular...

Indian Pharma Leads Global Generic Medicine Supply, says McKinsey Report

The latest report released by McKinsey & Company in Mumbai states that the soaring growth of exports exceeds that of the global average- positioning the...

India Leads Global Healthcare Innovation: Piyush Goyal

Union Minister of Commerce and Industry Piyush Goyal has said that the theme of BioAsia 2025, 'Catalyst of Change' captures India's growing leadership in...

Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025

India should transform from being production-centric to an innovation-dependent player on the world stage...

Telangana Secures Rs 11,100 Cr Life Sciences Investment at BioAsia 2025

Telangana received investment commitments from the life sciences sector of ?11,100 crore, which is meant to...

© 2025 India Pharma Outlook. All Rights Reserved.